Fengtong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fengtong Li has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Bingxin Zhang
Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China
2 shared publications - Lizhi Hu
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, China
2 shared publications - Bingkun Wang
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China
1 shared publication - Di Zhao
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China
1 shared publication - Hong Chen
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China
1 shared publication - Hong Cui
Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China
1 shared publication
Latest Publications
- 5 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 181, 116750
iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
- 5 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 181, 116750
iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
- 16 January 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 172, 116166
Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma
- 16 January 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 172, 116166
Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in scleroderma